SWM
STML

Sugarloaf Wealth Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Sugarloaf Wealth Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-300
Closed -$1K – 751
2020
Q1 		$1K Buy
300
+180
+150% +$1.17K ﹤0.01% 674
2019
Q4 		$1K Buy
+120
New +$1.19K ﹤0.01% 689

Sugarloaf Wealth Management's STML Position: Q2 2020 in Review

Sugarloaf Wealth Management sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 300 shares — an estimated $1K sold.

Sugarloaf Wealth Management first reported a position in STML in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Sugarloaf Wealth Management reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Sugarloaf Wealth Management sold 300 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $1K.
  • Sugarloaf Wealth Management first reported a position in Stemline Therapeutics, Inc. in Q4 2019 and held it in 2 quarters.
  • Sugarloaf Wealth Management's Stemline Therapeutics, Inc. position peaked at $1K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Sugarloaf Wealth Management's 13F filing for Q2 2020, filed 21 Jul 2020.